Stem Cell Market Insights, Competitive Landscape and Market Forecast-2027

Global Stem Cell Market was valued at USD 15.86 billion in 2021, growing at a CAGR of 10.34% during the forecast period from 2022 to 2027 to reach USD 28.61 billion by 2027. The Stem Cell market is witnessing positive growth owing to the rising prevalence of various chronic diseases and the need for their drug discovery, growing stem cell research activities, increasing cases of genetic disorders, significant adoption of stem cell therapies globally. In addition, increasing demand for biologics, accumulative focus on developing advanced products in the arena are some of the factors contributing to the Global Stem Cell Market.

Stem Cell Therapy: An Overview

Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. It is the next step in organ transplantation and uses cells instead of donor organs, which are limited in supply.

Download a sample copy of the market report- https://www.delveinsight.com/sample-request/stem-cell-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Recent Developmental Activities in the Stem Cell Market:

• On 17 May 2021, MEDIPOST completed the expansion of its production facilities for its knee osteoarthritis stem cell products, CARTISTEM® and SMUP-IA-01, and will start to prepare for GMP (Good Manufacturing Practice) certification.
• On February 5, 2021, Bristol Myers won FDA approval for its cancer cell therapy, Breyanzi, for the treatment of late-stage lymphoma.
• In August 2020, Cipla Limited announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval from the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first stem cell product to be approved globally for CLI treatment.

Key Takeaways from the Stem Cell Market Report Study

• Market size analysis for current Stem Cell market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Stem Cell market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Stem Cell market.
• Various opportunities available for the other competitor in the Stem Cell market space.
• What are the top performing segments in 2021? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current Stem Cell market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Stem Cell market growth in the coming future?

Stem Cell Market Dynamics

The Stem Cell market is witnessing a growth in product demand owing to various reasons, one of the key factors being the rising prevalence of various chronic diseases and the significant need for their drug discovery. Cell transplantation as a therapy for neurodegenerative disorders such as Diabetes type 1, Parkinson's disease, and Alzheimer's disease among others are already being explored. For instance, in January 2022, the first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy for advanced Parkinson's disease by BlueRock Therapeutics.

Request a sample copy of the market report- https://www.delveinsight.com/sample-request/stem-cell-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Stem Cell Market Factors

Another key factor responsible for the growth of the Stem Cell market is the increasing cases of genetic disorders. As genetic disorders occur due to anomalies of genetic origin, there has been a growing demand for stem cell therapies. Stem Cell therapy holds promise for treating a wide range of diseases, such as Cancer, Neonatal Encephalopathy, among others. For instance, on June 11, 2019, Mesoblast Limited announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for the use of mesenchymal stem cells (MSCs) in the treatment of newborns who lack sufficient blood supply and oxygen to the brain, a condition termed neonatal hypoxic-ischemic encephalopathy (HIE).

COVID-19 Impact on Stem Cell Market Report

Along with the factors mentioned above, the COVID-19 pandemic presented another major opportunity for growth for the manufacturers operating in the biopharmaceutical domain. The effect of the pandemic accelerated the drug development activities for the SARS-Cov-2 virus across the globe. The dire need for developing a vaccine to contain the pandemic led to the approval and emergency use authorization of numerous vaccines for prophylactic use across the globe. Moreover, some of the recent studies have suggested that stem cell therapy has a remarkable effect on reducing mortality and morbidity of patients with COVID-19. Therefore, different candidates under development might prove as a potential therapy for COVID-19 infection.

Stem Cell Market Segment Analysis
Stem Cell Market By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, Others), By Therapy Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy), By Usage (Regenerative Medicine, Drug Discovery and Development), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World). In the Therapy Type segment of the Stem Cell Market, Allogeneic Stem Cell Therapy is estimated to hold the highest share in the Stem Cell market during the forecast period.

Stem Cell Market Companies
Some of the key market players operating in the Stem Cell market include Osiris Therapeutics, Inc. (Smith+Nephew Inc.), MEDIPOST Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., NuVasive®, Inc., Stempeutics Research Pvt Ltd., Bristol-Myers Squibb Company, Organogenesis Inc., Takeda Pharmaceutical Company Limited, CHIESI SAS, Tegoscience, Biosolution Co., Ltd., CORESTEM, Inc., CO.DON, NIPRO and others.

Get To Know More Related Details- https://www.delveinsight.com/report-store/stem-cell-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Stem Cell Market Report Introduction
2. Stem Cell Market Executive Summary
3. Regulatory and Patent Analysis
4. Stem Cell Market Key Factors Analysis
5. Stem Cell Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Stem Cell Market
7. Stem Cell Market Layout
8. Stem Cell Market Global Company Share Analysis - Key 3-5 Companies
9. Stem Cell Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

For any query & doubt, connect with our Business Consultant- https://www.delveinsight.com/report-store/stem-cell-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yashveer Bhardwaj
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.